Company · Foster City, California, United States
Gilead Sciences, Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 2
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 18
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ATRIPLA | 02300699 | Cancelled Post Market | |
| DAUNOXOME LIPOSOMAL - IV 2MG/ML, 50MG/VIAL | 02218046 | Cancelled Post Market |
Notices of Compliance
Newest first.
- ATRIPLAMarch 20, 2018 · NOC 20642 · New Drug Submission (NDS)
- HEPSERAOctober 6, 2008 · NOC 9812 · Supplement to a New Drug Submission (SNDS)
- VIREADSeptember 3, 2008 · NOC 9755 · Supplement to a New Drug Submission (SNDS)
- VIREADJanuary 17, 2008 · NOC 9304 · Supplement to a New Drug Submission (SNDS)
- TRUVADAJanuary 17, 2008 · NOC 9305 · Supplement to a New Drug Submission (SNDS)
- TRUVADASeptember 11, 2007 · NOC 9015 · Supplement to a New Drug Submission (SNDS)
- VIREADSeptember 11, 2007 · NOC 9017 · Supplement to a New Drug Submission (SNDS)
- HEPSERAMarch 5, 2007 · NOC 8632 · Supplement to a New Drug Submission (SNDS)
- HEPSERAMarch 5, 2007 · NOC 8633 · Supplement to a New Drug Submission (SNDS)
- TRUVADAOctober 27, 2006 · NOC 8355 · Supplement to a New Drug Submission (SNDS)
- VIREADOctober 25, 2006 · NOC 8351 · Supplement to a New Drug Submission (SNDS)
- TRUVADAJanuary 6, 2006 · NOC 7675 · New Drug Submission (NDS)
- EMTRIVANovember 21, 2005 · NOC 7621 · New Drug Submission (NDS)
- VIREADJuly 20, 2005 · NOC 7257 · Supplement to a New Drug Submission (SNDS)
- HEPSERADecember 3, 2004 · NOC 5933 · Supplement to a New Drug Submission (SNDS)
- HEPSERAAugust 27, 2003 · NOC 29 · New Drug Submission (NDS)
- VIREADMarch 18, 2003 · NOC 3621 · New Drug Submission (NDS)
- DAUNOXOME LIPOSOMALAugust 23, 2000 · NOC 1096 · New Drug Submission (NDS)